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The high-mannose patch on the HIV-1 envelope (Env)
glycoprotein is the epicenter for binding of the potent
broadly neutralizing PGT121 family of antibodies, but
strategies for generating such antibodies by vaccina-
tion have not been defined. We generated structures
of inferred antibody intermediates by X-ray crystal-
lography and electron microscopy to elucidate the
molecular events that occurred during evolution of
this family. Binding analyses revealed that affinity
maturation was primarily focused on avoiding, ac-
commodating, or binding the N137 glycan. The over-
all antibody approach angle to Env was defined very
early in the maturation process, yet some variation
evolved in the PGT121 family branches that led to
differences in glycan specificities in their respec-
tive epitopes. Furthermore, we determined a crystal
structure of the recombinant BG505 SOSIP.664
HIV-1 trimer with a PGT121 family member at 3.0 A˚
that, in concert with these antibody intermediate
structures, provides insights to advance design of
HIV vaccine candidates.
INTRODUCTION
The envelope glycoprotein trimer (Env) on the surface of HIV-1 is
the sole target for neutralizing antibodies (nAbs) during the
host immune response. Env is heavily glycosylated and the
host-derived glycans conceal much of the protein surface from
antibody recognition. Despite the extensive ‘‘glycan shield,’’
the immune system is capable of evolving an antibody response
over time that is both potent and broadly neutralizing. A number
of these broadly neutralizing antibodies (bnAbs) penetrate theImmglycan shield and engage both carbohydrate and protein com-
ponents (Burton and Mascola, 2015; Ward and Wilson, 2015).
To date, several bnAbs have been isolated from HIV-infected in-
dividuals that bind to glycans located in a high-mannose patch
centered on the N332 glycan in gp120 and to protein compo-
nents at the base of the V3 loop (Garces et al., 2014; Kong
et al., 2013; Mouquet et al., 2012; Pejchal et al., 2011).
Members of the PGT121 family of Abs (PGT121, 122, 123, and
124) all recognize this high-mannose patch and were isolated
from a single donor (donor 17) infected with a clade A HIV virus
(Walker et al., 2011). Another set of PGT121 variants, including
10-1074, have also been isolated and characterized (Garces
et al., 2014; Mouquet et al., 2012). PGT121, 122, and 123 are
closely related members of the largest branch of the family,
whereas PGT124 and 10-1074 reside on the other main branch
(Sok et al., 2013). This family of Abs, although preferentially bind-
ing to the glycan at N332, can counter viral escape in the context
of some isolates by binding to alternate, proximal glycans when
the N332 glycan is absent (Garces et al., 2014; Sok et al., 2014).
However, this promiscuity is complex and strain dependent.
Neutralization assays have shown that the PGT121 family mem-
bers engage or avoid different glycans throughout the affinity
maturation process (Garces et al., 2014; Sok et al., 2014). Affinity
maturation of HIV-1 bnAbs is driven by extensive somatic hyper-
mutation (SHM) (Eisen and Siskind, 1964; Goidl et al., 1968;
McKean et al., 1984) over a period of one to several years (Do-
ria-Rose et al., 2009; Sather et al., 2009) through a process
that might prove challenging to mimic during vaccine design.
Nonetheless, inferred Ab pairs of the PGT121 family (3H+3L,
9H+3L, and 32H+3L), identified by next-generation sequencing
and exhibiting considerably less SHM than the corresponding
mature Abs such as PGT121 or PGT124, still have notable
broadly neutralizing capability (Sok et al., 2013).
Here, we present a comprehensive study of the molecular
events associated with increased SHM and affinity maturation
in the PGT121 family. Using site-directed mutagenesis, com-
bined with isothermal titration calorimetry (ITC), we measuredunity 43, 1053–1063, December 15, 2015 ª2015 Elsevier Inc. 1053
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Figure 1. Representation of the Relative
Binding Affinities of Antibody PGT121 Fam-
ily Members to Wild-Type and Glycan-
Variant SOSIP Trimers
Schematic representation of the PGT121 family
phylogenetic tree with heavy chains paired with the
corresponding light chains. Dissociation constants
(Kd) were determined by ITC for selected mem-
bers of this family from inferred germline to in-
termediates (precursors) and to affinity-matured
Abs in complex with SOSIP.664 trimers and N137A
or N332A glycan knock-out variants, expressed in
either 293S (A) or 293F (B) cells (Figure S1). The
fold changes in binding affinity (nM) (Figure S1B)
upon glycan removal were used to estimate how
the N137 glycan contributes to affinity maturation.
A relative scale for both positive and negative
contributions to the Ab affinity was determined
based on the extent of the changes in dissociation
constants (see also Figure S1B for complete ther-
modynamic data). Top right: surface representa-
tion of the location of glycans (colored) that interact
with PGT121 family with the variable heavy chain in
gray and variable light chain in light brown.Ab-antigen dissociation constants (Kd) at several distinct stages
of affinity maturation. Moreover, crystal structures of putative
precursor Abs of the PGT121 family have revealed the molecular
details that led to affinity and specificity changes. Using X-ray
crystallography and electron microscopy (EM), we have deter-
mined several structures of inferred intermediate Abs in complex
with the soluble BG505 SOSIP.664 trimer (Env trimer corre-
sponding to an HIV-1 clade A virus strain) and examined their
specificity and angle of approach to Env throughout key steps
in maturation of the PGT121 family. We have also determined
the crystal structure of the 3H+109L Ab, whose heavy chain
has the least SHM from the inferred germline PGT121 heavy
chain, in complex with the Env trimer at 3.0 A˚ resolution (overall
data completeness of 100%). Previous BG505 SOSIP.664 trimer
crystals (Julien et al., 2013a; Pancera et al., 2014) have suffered
from anisotropic diffraction that has limited the resolution
achievable, but we overcame that problem by complexing the
trimer with 3H+109L Abs and 35O22 Fabs. The outcome is an
increased structural and functional understanding of this HIV-1
vaccine candidate and how it is recognized by the human im-
mune system.
RESULTS
Affinity Maturation Is Focused on Accommodating the
N137 Glycan
To study themolecular events associatedwith affinitymaturation
of the PGT121 family, we paired each of the inferred intermediate
heavy chains 3H, 9H, and 32H with the intermediate light chain
3L, as previously described (Sok et al., 2013), and used ITC to
quantify Ab binding to BG505 SOSIP.664 trimers (produced in
293S cells that yield primarily high-mannose [Man5-9] glycans).
Although the trimer binding of the inferred PGT121 germline Ab
was too weak to measure (Figure S1A), we successfully charac-
terized the binding of other inferred precursors including 3H+3L,1054 Immunity 43, 1053–1063, December 15, 2015 ª2015 Elsevier Inwhich had heavy and light chains that most closely resembled
the inferred germline Ab (Figures 1 and S1). During the matura-
tion process, binding affinity was differentially gained in each
of the two major branches of the PGT121 family (Figures 1
and S1B). Indeed, when tested against BG505 SOSIP.664, the
9H+3L antibody displayed a 6-fold increase in binding affinity
for the BG505 SOSIP.664 trimer compared to 3H+3L, an earlier
inferred Ab pair with low SHM common to both branches of
the PGT121 family. In contrast, the affinity gain for 32H+3L
from the PGT124 branch was modest compared that of 3H+3L
(Figures 1 and S1B). A very different scenario arose in further
affinity maturation. The PGT124 affinity for the Env trimer was
13 times higher than that of 32H+3L, whereas the PGT122
affinity decreased slightly compared to that of 9H+3L (Figures 1
and S1B). Nevertheless, for PGT122, a large gain in enthalpy was
observed but compensated for by a large loss in entropy (Fig-
ure S1B), which might in part have been due to slight differ-
ences in interaction with the N137 glycan (Garces et al., 2014)
that decreased its conformational mobility. As expected, we
observed an overall increase in binding affinity at every step of
affinity maturation of the PGT121 family.
One particular feature of the PG121 family of bnAbs is the
‘‘open face’’ formed by complementarity determining regions
(CDR) H1, H2, and H3, which is used either to bind the N137
glycan (PGT121-123) or to simply accommodate or avoid this
sugar (PGT124) (Garces et al., 2014; Julien et al., 2013b; Mou-
quet et al., 2012). Therefore, we also investigated Ab binding
to a variant trimer with a point substitution that knocked out
the N137 glycan (BG505 SOSIP.664-N137A). For all Abs tested,
the affinity and stoichiometry of trimer binding was increased
when the N137 glycan was absent (Figures 1 and S1B). Indeed,
the Kd of 35 nM for the binding of early precursor 3H+3L Ab to the
SOSIP.664-N137A trimer represented an15-fold enhanced af-
finity versus its binding to SOSIP.664 (i.e., wild-type trimer) and
was comparable to the Kd of 32 nM for the mature PGT124c.
Figure 2. Angle of Approach to the Env Trimer
by PGT121 FamilyMembers asDetermined by
EM
Schematic representation of Abs from the PGT121
phylogenetic tree (Sok et al., 2013) (displayed hori-
zontally) in complex with SOSIP trimer as deter-
mined from negative-stain EM reconstructions for
Ab:SOSIP complexes. The correlation values were
calculated by fitting the EM reconstruction of the
3H+3L:SOSIP.664-N137A complex into the corre-
sponding reconstructions of the 32H+3L:SOSIP.664,
PGT124:SOSIP.664, 9H+109L:SOSIP.664, and
PGT122:SOSIP.664 complexes (please see Fig-
ure S2).bnAb and wild-type trimer (Figures 1 and S1B). The 32H+3L anti-
body, a more mature Ab within the PGT124 branch, also ex-
hibited an enhanced affinity (16-fold) upon N137 removal,
which was higher than the affinity of the final-stage PGT124
affinity-matured Ab. Thus, perhaps not surprisingly, the affinity
of PGT124 for the SOSIP.664-N137A trimer was also 5-fold
enhanced (Figures 1 and S1B). The same trend was also
observed for the PGT122 branch, where the affinities of the inter-
mediate 9H+3L and the mature PGT122 bnAbs were enhanced
by11- and5-fold, respectively, for SOSIP.664-N137A versus
the wild-type trimer (Figures 1 and S1B). Hence, the N137 glycan
impeded Env binding of all PGT121 family members tested,
implying that accommodating this glycan was the major driving
force behind affinity maturation.
To correlate our ITC data with neutralization assays, we also
measured binding of PGT121 family Abs to wild-type and
N137A SOSIP.664 trimers that were produced in 293F cells,
where the glycans could be fully processed into complex and/
or hybrid forms that probably more closely mimic the glycan
composition on the viruses used in the neutralization assays.
The resulting ITC data were similar to those obtained using
293S cell-produced trimers, in that the affinities of all the inter-
mediate and mature Abs were increased for the SOSIP.664-
N137A trimer versus wild-type (Figures 1 and S1B). However,
the PGT122 affinity decreased when Env was produced in
293F cells (Figures 1 and S1B), which might reflect differences
in binding or avoiding complex glycans (i.e., larger and more
complex carbohydrate structures that would be naturally
present in some glycosylation sites on the virus and found in
proteins expressed in 293F cells, as compared to high-
mannose-only glycans in 293S cells) in the vicinity. Indeed, the
PGT122-BG505 SOSIP.664 trimer structure showed that the
light chain was in close proximity to the N156 and N301 glycans
and distal from the N137 glycan (Figure 1; Julien et al., 2013a). To
investigate whether pairing of precursor Ab heavy chains (3H,
9H, and 32H) with a mature light chain (109L) (Sok et al., 2013)
would affect trimer binding, we tested binding of hybrid Abs
to the N137A SOSIP.664 trimer that contained the following
heavy and light chains: 3H+109L, 9H+109L, and 32H+109L (Fig-Immunity 43, 1053–1063, Dures 1 and S1B). For each hybrid Ab, a
slight increase in binding was observed
over an Ab containing the precursor 3L light
chain (Figure S1B), implying that the more
mature 109 light chain has evolved toaccommodate the N156 and N301 glycans. Hence, these two
glycans also probably play a role in the affinity maturation of
the PGT121 family.
The PGT121 Family Angle of Approach to Env Is Largely
Defined at Early Stages of Affinity Maturation
The precise angle of approach to the trimer is important for bnAbs
that recognize the CD4 binding site, because small variations can
have a substantial adverse effect on HIV-1 neutralization (Chen
et al., 2009). However, bnAbs that interact with the central N332
glycan can approach their target from several directions because
access to the oligomannose patch is not as restricted (Kong et al.,
2013). It is not clear how and when the approach angle (rotation
and tilt) is set for any particular family of bnAbs and whether it
changesduring theaffinitymaturationprocess.Because this infor-
mation would be valuable for immunogen design, we determined
negative-stain EM structures of BG505 SOSIP.664 trimer com-
plexes of the inferred intermediates and affinity-matured Abs
described above (Figures 2 and S2). To prepare a stable, higher-
affinity, complex with 3H+3L, we used the SOSIP.664-N137A
trimer. The resulting negative-stain EM reconstruction could be
fitted to a similar reconstruction of 32H+3L with the wild-type SO-
SIP.664 trimer with a correlation of 0.92, indicating that both Abs
adopt the same overall angle of approach. Thus, the presence or
absence of the N137 glycan does not grossly affect the approach
angle. This observation also applies to the mature PGT124 Ab, as
the equivalent correlation was 0.91 (Figure 2). For the PGT122
branch, correlations of the 3H+3L:SOSIP.664-N137A reconstruc-
tion with the 9H+3L and PGT122 reconstructions with SOSIP.664
were 0.87 and 0.96, respectively, again suggesting a general con-
servation of the approachangle of the antibodies to theEnv trimer.
These findings indicate that the PGT121 family angle of approach
to Env is largely defined at early stages of antibody selection and
affinity maturation.
Crystal Structure of the BG505 SOSIP.664 Trimer at
3.0 A˚ in Complex with the 3H+109L Ab Precursor
Crystal structures for mature PGT124 and PGT122 bnAbs
in complex with their respective trimer epitopes have beenecember 15, 2015 ª2015 Elsevier Inc. 1055
Figure 3. The HIV-1 SOSIP Env Trimer Struc-
ture at 3.0 A˚ Resolution
(A) Ribbon representation of gp41 in the context of
the BG505 SOSIP.664 trimer. The gp120 subunits
are shown in surface representation and gp41 is
shown in ribbon representation.
(B) Ribbon representation of one protomer with the
newly defined region of 20 residues, located within
the HR1 helix, and connecting the I548 and I568
residues, highlighted with a yellow surface. The
position of the I559P mutation in the trimer is also
indicated. On the right side is an enlarged image of
the region between residues I548 and I568 (in red)
and a 2Fo-Fc electron density map contoured at
0.5s (yellow mesh).
(C) Detailed representation of mutations introduced
into the gp41 structure to stabilize the SOSIP.664
trimer with their yield and Tm values.previously reported (Garces et al., 2014; Julien et al., 2013a; Pan-
cera et al., 2014). Here, we sought to compare the crystal struc-
ture of antibodies with less mature H or L chains of the PGT121
familywithmoremature antibodies of the family. The high binding
affinity of the inferred heavy chain precursor 3H (paired with the
mature 109L light chain) for the BG505.SOSIP.664 trimer in the
absence of the N137 glycan (Figures 1 and S1B) provided an
opportunity to crystallize that complex. Addition of 35O22 Fab
that binds to gp41 (Pancera et al., 2014) further facilitated forma-
tion of X-ray quality crystals and enabled the crystal structure
of 3H+109L in complex with BG505 SOSIP.664-N137A and
35O22 Fab to be determined at 3.0 A˚ resolution (Figure 3A and
Table S1).
This 3.0 A˚ crystal structure allowed us to interpret residues
that were not visible or interpretable in previous Env trimer
structures (Julien et al., 2013a; Pancera et al., 2014), as well
as to improve the definition of side-chain rotamers and, hence,
obtain further improvements to the Env trimer model. The over-
all structure (Figures 3A and 3B) was very similar to that in Pan-
cera et al. (2014) (0.4 A˚ Ca root-mean-square deviation
[RMSD]), but some additional features were now visible, espe-
cially in gp41. The previous BG505 SOSIP.664 crystal structures
have poor or no density in the central region of the gp41 heptad
repeat 1 (HR1) sequence (residues I548 to I568) that connects
the top of the HR1 helix with the fusion peptide proximal region
(FPPR) (Julien et al., 2013a; Pancera et al., 2014). Although
there were still some interpretative difficulties, we saw signifi-
cantly more density in this region (Figures 3B and S3A). Even
so, the more diffuse electron density compared to the surround-
ing areas suggests that this region was either inherently very
flexible in the pre-fusion state of the trimer or that the trimer-
stabilizing I559P mutation disrupted the native secondary struc-
ture. Overall, the electron density map suggested that we might
have captured a structure that transitions between an a helix
and a more extended loop (Figure 3B). Moreover, it also illus-
trates the key role that the I559P mutation plays in stabilizing
the trimer in a pre-fusion conformation.
We used this new structural information on HR1 to design
mutations to verify the amino-acid register that we built for1056 Immunity 43, 1053–1063, December 15, 2015 ª2015 Elsevier Inthe now complete HR1 region and to possibly increase the sta-
bility of the SOSIP.664 trimers. The L555K substitution was de-
signed to stabilize the trimer by introducing a hydrogen bond
between gp41 in one protomer with gp120 from an adjacent
protomer and an L556K substitution to create a hydrogen
bond between HR1 in gp41 and a helix 0 in gp120 within a pro-
tomer. When co-expressed with furin under standard condi-
tions, the resulting L555K and L556K trimers were fully cleaved
as shown by the conversion of gp140 bands to gp120 and
gp41 on a reducing SDS-PAGE gel (Figure S3B). Moreover,
analysis by native-PAGE gel showed that these mutants have
also the same molecular weight as the wild-type (Figure S3C).
Hence, the point substitutions do not adversely affect the over-
all trimer conformation. Although the melting temperatures
were essentially unchanged, the yields of the L555K and
L556K trimers were increased by 3- and 2-fold, respec-
tively, compared to wild-type, when purified on a PGT145
bnAb affinity column (Figure 3C). A SOSIP.664-L555C/Q49C
double mutant was then designed to introduce a new disulfide
bond to covalently link gp41 with the gp120 N terminus of the
adjacent protomer (Figure 3C). Although analysis by SDS-
PAGE and native-PAGE gel showed that this double mutant
exhibits a native conformation (Figure S3C), the expression
yield of well-ordered trimers was 4-fold less than wild-type.
However, its melting temperature of 75.2 is the highest that
we have observed to date for a SOSIP.664 trimer variant
(Figure 3C).
We used a panel of bnAbs, non-neutralizing antibodies (non-
nAbs), and CD4 to probe the antigenic structure of the above
trimer mutants by ELISA, and we found that bnAbs and CD4
bound equivalently to wild-type BG505 SOSIP.664 (Figure S3D).
Importantly, for the double mutant L555C/Q49C, binding of
the 17b non-bnAb to its CD4-induced epitope was decreased
5-fold (Figure S3D).
Thus, the HR1 model based on the higher-resolution structure
(Figure 3B) was strongly validated by the structure-based mu-
tants, implying that additional mutations can now be designed
to further stabilize the pre-fusion form of the trimer and/or facil-
itate its production for vaccine trials.c.
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Figure 4. Crystal Structure of the BG505
SOSIP.664 Trimer in Complex with Fab
3H+109L and Fab 35O22
(A)A ribbon representationof the ternarycomplexof
Fab3H+109L (orangeandbrown for heavy and light
chains, respectively) and Fab 35O22 (light gray and
dark gray for heavy and light chains, respectively)
bound toanEnvprotomer (gp120 is in light bluewith
N137 deleted from the trimer and gp41 is in green)
and with the glycans represented as spheres.
(B) Superimposition of 3H+109L with PGT122 (on
top) and with PGT124 (center), and PGT122 with
PGT124 (bottom)on theBG505SOSIP.664trimer to
show their relative dispositions.Only theCDR loops
and LFR3 of 3H+109L (in orange) and PGT122 (in
gray) are shown.Right, schematic representation of
the relative rotation indegrees () of theFV regionsof
the different Abs on the epitope surface.
(C) Superimposition of the structures of the three
complexes based on the gp120 subunits only (in
ribbon representation), with the variable region of
each Ab represented as a solid surface and the
glycans in spheres. The vertical axes that point
toward the center of epitope were used to calcu-
late the comparative tilt angle for each Ab in rela-
tion to each other.Interaction of 3H+109L with the BG505 SOSIP.664
Trimer
The 3H+109L Fab binds to the highly conserved ‘‘GDIR’’ peptide
motif at the base of V3 (residues 324–327) and to the oligoman-
nose glycan attached to N332 (Figure 4A). Although the electron
density suggested a Man8GlcNAc2 glycan (Man8), the Ab could
also accommodate a Man9 glycan without steric clashes. Addi-
tional electron density at N156 and N301 could be assigned to
Man3GlcNAc2 and Man2GlcNAc2 moieties, respectively (Fig-
ure 4A), but neither appears to establish a close contact with
the Fab when the trimer is expressed in a high-mannose
form in 293S cells. Because the 3H+3L combination Ab did
not yield any trimer crystals despite extensive attempts, we
compared its negative-stain EM structure in complex with
BG505 SOSIP.664-N137A with the 3H+109L:BG505 SO-
SIP.664-N137A crystal structure (Figures S2E and S2F). Despite
the differences in resolution, the two structures were readily
compared because of the availability of higher-resolutionmodels
that can be fit into the EM reconstruction (Figures S2E and S2F).Immunity 43, 1053–1063, DThe X-ray and EM structures are in agree-
ment, suggesting that pairing 3H with
either the 3L (inferred precursor) or the
109L (mature) light chain does not sub-
stantially affect antibody approach to the
trimer and, hence, interaction with the
epitope. To further analyze the 109L
conformation, we superimposed it on the
3L light chain derived from the 9H+3L
Fab crystal structure (Figure S2G and
Table S1). Both structures aligned well,
with a Ca RMSD of 0.6 A˚. Moreover,
109L shared 82% identity of its VL with
3L, 95% with PGT124, but only 69% withPGT122 (Figure S2H). This indicates that 109L is phylogeneti-
cally more related to the PGT124LC than to the PGT122LC
(Sok et al., 2013).
Comparisons of 3H+109L with PGT122 (PDB: 4TVP) and
PGT124 (PDB: 4R2G), in complex with the BG505 Env trimer
and JRCSF gp120 core, respectively (Figure 4B), showed the
CDR H3, L1, and L3 loops that contact the epitope core (GDIR
and N332 glycan) were highly conserved (0.38 and 0.42 A˚ Ca
RMSD for 3H+109L versus PGT124 and 3H+109L versus
PGT122, respectively) (Figure S4A). The CDR H1 and H2 loops
that comprise the open face were also conserved in shape
among the 3H, PGT122, and PGT124 Abs (Figure S4C) but
differed substantially in their relative disposition on the trimer
(Figure 4B). To further investigate this variation, we determined
the rotation angle of the Fab variable region (FV), which consisted
of variable heavy and variable light chain domains, around the
GDIR motif (after superposition of their gp120 chains). We
observed that PGT124-FV is rotated by 10.4
 and 10.8 relative
to 3H+109L-FV and PGT122-FV on gp120, respectively, so thatecember 15, 2015 ª2015 Elsevier Inc. 1057
Figure 5. Crystal Structures of the PGT121
Family Members Displayed from Germline
to Mature Antibodies
Mapping of the somatic hypermutations (SHM) (in
red spheres) onto the variable region of both heavy
chain and light chain of the precursors and mature
antibodies of the PGT121 lineage. The number of
SHM (no. residues) for each antibody at each step in
evolution is indicated.CDRs H1 and H2 of PGT124-Fv are displaced away from the
N137 glycan. In contrast, for PGT122-FV, the corresponding
deviation from the orientation of 3H+109L-FV on gp120 is only
1.4 (Figure 4B).
Differences in the approach angle are defined not only by the
rotation of one Ab relative to the other, but also by differences
in the Ab tilt angle relative to the trimer surface. The PGT124
tilt angle differed by 5 compared to PGT122 and 3H+109L
whereas PGT122 and 3H+109L differed by only 1 in this regard
(Figure 4C). Thus, PGT124 also tilted away from the N137 glycan
and toward N301, consistent with the same trend seen in the
rotation angle. These differences in Ab rotations and tilt sug-
gested the PGT124 branch of the family reduced contact with
the N137 glycan during affinity maturation. Indeed, calculations
of the surface areas that are buried when these Abs bind to the
BG505 SOSIP.664 trimer (Table S2) indicated that PGT124 bur-
ies 3-fold less heavy-chain surface area on N137 (108 A˚2),
compared to PGT122 (300 A˚2) or 3H (260 A˚2).
We then compared the BG505 SOSIP.664-N137A high-reso-
lution structure with the wild-type BG505 trimer crystal structure
(PDB: 4TVP) to identify any differences, especially in the glycans
near N137 (Figure S4B). The conformation and/or orientation of
the surrounding glycans (N332, N301, and N156) were not sub-
stantially affected by the absence of the N137 glycan. Indeed,
the only changes were in the V1 loop upstream from A137, in a
region that does not interact with PGT121 family Abs (Fig-
ure S4B). Hence, deletion of the N137 glycan from the Env sur-
face increased antibody affinity without greatly affecting the
native structure of PGT121 epitope.
The PGT121 Family of Antibodies Vary Their Binding
Sites and Angle of Approach to Accommodate the N137,
N301, and N156 Glycans during Affinity Maturation
Crystal structures show that Abs of the PGT121 lineage have
a common overall architecture: an open face comprised of the1058 Immunity 43, 1053–1063, December 15, 2015 ª2015 Elsevier Inc.three heavy-chain CDRs and an ‘‘elon-
gated face’’ formed by the light chain along
with portions of CDR H3 (Figure S4C; Ju-
lien et al., 2013b; Mouquet et al., 2012).
Whereas the elongated face mainly inter-
acts with the GDIR peptide and the N332
glycan, the open face interacts with the
N137 glycan. Moreover, whereas the inter-
actions with the GDIR motif and the N332
glycan are mostly defined at the earliest
stages of the affinity maturation process
(Figure S4A; Garces et al., 2014), the bind-
ing affinity data suggested that differentstrategies have evolved for interacting with the N137 glycan in
the different branches of the PGT121 lineage (Figure 1). Accord-
ingly, we determined crystal structures of key heavy chain pre-
cursors (3H+109L, 9H+3L, 32H+109L) at branch points in the in-
ferred phylogenetic tree of the PGT121 family to compare with
themature bnAbs (PGT122 and PGT124) (Table S1 and Figure 5).
We then modeled a N137 complex glycan in the open face of the
precursor Ab by superimposition with the PGT121 structure (Ju-
lien et al., 2013b; Mouquet et al., 2012). We identified potential
clashes between the earliest precursor Ab 3H and the complex
glycan (Figures 6A and S5A) that were reduced or eliminated in
9H+3L and PGT121 (Figures 6A, S5A, and S5B). Indeed, resi-
dues (Y32, D53, and Q97) in the early precursor 3H that clashed
with the glycan as well as others in the vicinity (Q96, Y100l, and
Y100n) are eithermutated to residues with a smaller side chain or
adopt a different rotamer (H32, D53, Q96, H97, T100l, and
F100n) (Figure S5) in 9H. In PGT121, some residues were further
mutated (K53) or acquired a different rotamer (H97) in PGT121 to
interact better with the N137 glycan (Figure 6A). Indeed, K53 and
H97 were previously defined as key residues for interaction of
PGT121 with a complex glycan (Julien et al., 2013b; Mouquet
et al., 2012). In contrast, in the PGT124 branch, these residues
are conserved from the 3H precursor (Figures 6A, S5A, and S5B).
The light chain framework 3 (LFR3) of the PGT121 family has a
three-residue insertion after residue L67 (67a,b,c) that is impor-
tant for HIV-1 neutralization (Sok et al., 2013). This insertion oc-
curs early in affinity maturation and enabled F67c at the tip of
LFR3 to interact with I323 and G324 in the Env GDIR motif (Fig-
ure S5C),which is shielded in part by theN301 glycan (Figure 6B).
A high degree of conformational flexibility was found at the LFR3
tip (Figure 6B) in the three mature light chains (PGT122, PGT124,
and 109L) when comparing the free and bound forms of these
Abs. Furthermore, F67c in the 109L and PGT124 Abs must
change its side-chain rotamer from its unliganded form to avoid
a clash with the N301 glycan. Although the LFR3 tip appeared to
Figure 6. Molecular Details of the Interaction
between N332 Proximal Glycans and PGT121
Family Members
(A) Interaction of N137 and the ‘‘open face’’ of the
members of the PGT121 family. The glycan, in red, is
modeled from the PGT121 structure crystalized with
a complex glycan in the open face. The evolution of
critical residues (in ball-and-stick representation)
throughout affinity maturation of the PGT122 and
PGT124 branches is highlighted in enlarged boxes.
The role each residue plays in the glycan interaction
at different stages in the affinity maturation is high-
lighted to the right of each enlarged image.
(B) Interaction between the N301 glycan (in yellow
ball-and-stick) and the light-chain FR3 (cartoon
representation).
(C) The N156 glycan (in blue ball-and-stick), repre-
sented only as its Man3 form.be more conserved between the unbound and bound states of
PGT122 (Figure 6B), F67c adopted a different rotamer compared
to the 109L and PGT124 Abs.
The light chain N terminus of PGT121 family Abs acquired a
deletion of as many as seven residues during affinity maturation
that increases neutralization potency (Sok et al., 2013). Our
structural data show that N156 is proximal to this deleted
N terminus. Hence, although the glycan at N156 is only partially
observed in the crystal structure, we can infer that it would
probably clash with the N terminus if present, which explains
the deletion (Figure 6C). Thus, key modifications to the antibody
paratopes were able to accommodate the spectrum of glycans
in vicinity of their epitopes and thereby increase antibody binding
affinity.
DISCUSSION
Affinity maturation normally involves several rounds of exposure
to an antigen in order to drive B cells to produce antibodies with
successively greater affinities (Berek et al., 1991; Eisen and
Siskind, 1964; Goidl et al., 1968; Pappas et al., 2014). For the
PGT121 family, affinity maturation not only selects for more pro-
ductive contacts between antibody and antigen or more rigid
conformations of their complementarity determining regions
(CDRs) (Sok et al., 2013), but also removes clasheswith glycan(s)
on the epitope perimeter. The binding data suggested that many
of the productive contacts between the final bnAb and its pep-
tide-glycan epitope are established at a very early stage in matu-
ration of the lineage and that the subsequent steps are largely
focused on how to cope with neighboring glycans, mainly
N137.Removal of theN137glycan from the trimer hadaprofound
effect on antibody binding affinity at all stages in the evolution of
PGT121 lineage, suggesting that several rounds of affinity matu-
ration are required to minimize the blocking effect of this glycan.
Although binding studies can be very informative on the
course of affinity maturation, here we sought more detailedImmunity 43, 1053–1063, Dmolecular information through the determi-
nation of crystal and EM structures of the
Env trimer in complex with inferred inter-
mediates in the PGT121 lineage. We found
that the two branches of the lineage followdifferent strategies to deal with blocking glycans. The PGT124
branch evolved so that: (1) the antibody approaches the epitope
at a 5 tilt away from N137 and toward the N301 glycan
compared to PGT122 and (2) the variable region (FV) corre-
spondingly rotated 10.8 clockwise so that the CDR H1 and H2
loops move away from the N137 glycan. For the PGT121-123
branch, the strategy differs: (1) antibody residues whose side
chains clash with the N137 glycan are replaced by smaller side
chains (9H+3L) and (2) mutations that establish productive con-
tacts with the N137 glycan are then selected (PGT121-123). The
shift in the focus of the PGT121-23 branch toward the N137
glycan might have been a consequence of the loss of the N332
glycan from the infecting virus at some stage during its evolution
in the patient (Figure S6) because N137 can substitute for N332
in the context of certain isolates (Sok et al., 2014). The high-affin-
ity interaction of PGT124 that involves only a single glycan (the
N332 glycan site is 72% conserved across 3,045 HIV-1 strains
in the Los Alamos HIV Sequence Database) could have exerted
pressure on the virus to escape by deleting the N332 glycan
(Figure S6). In this scenario, the evolution of antibodies in the
PGT122 branch to productively bind the N137 glycan (72%
conserved) using the open face would sustain an overall neutral-
ization response against the virus (Figure S6). This mechanism of
cooperation between different antibodies has previously been
suggested for CD4 binding site Abs from two different lineages
(Gao et al., 2014). Although our observations involved a single
lineage of antibodies, they demonstrated how different anti-
bodies in the same family can evolve synergistically. Our hypoth-
esis is supported by the structural data showing that the early
inferred precursor, 3H, binds the GDIR motif and N332 glycan
in the same way as the mature bnAbs PGT122 and PGT124.
Although the PGT122 branch depends on the N332 glycan
throughout its evolution, the affinity of mature PGT122 was
2 fold higher for the BG505 SOSIP trimer when N332 was
absent (Kd values: SOSIP.664 174.0 nM versus SOSIP.664-
N137A 82.4 nM), but we do not know if this is the case for otherecember 15, 2015 ª2015 Elsevier Inc. 1059
strains. Notwithstanding, these data reinforce the argument that
PGT122, in contrast to PGT124, became more focused on the
N137 glycan (Figure S6).
The 3H precursor recognizes the N332 glycan and the GDIR
motif, which acted as a double anchor for this lineage. These
interactions probably define the initial angle of approach for
PGT121 family of Abs. Indeed, whether theN137 blocking glycan
was present or not, the angle of approach in the PGT122 branch
remained unchanged during affinity maturation. However,
PGT124 must acquire additional mutations to avoid the N137
glycan and boost its affinity for the trimer.
We can now utilize such lessons for designing an immunogen
that triggers this antibody lineage. For example, to elicit PGT121,
122, and 123 bnAbs (all in the same evolutionary branch), several
steps could be designed to drive precursors tomature during the
course of immunization. First, exposing B cells to a stabilized
trimer that displays the PGT121-124 epitope(s) might allow an
appropriately shaped Ab to be selected; i.e., a precursor with
open and closed faces that will set the angle of approach for
the lineage. Immunogens lacking the N332 glycan could then
mimic escape of the infected virus from PGT124, so as to
enhance interaction with surrounding glycans, such as N137,
and eventually induce PGT122-like bnAbs. In contrast, to drive
maturation of PGT124 Abs (in the other evolutionary branch),
the continuous presence of not only N332 but also the N137
glycan might be crucial to slightly modify the angle of approach
and thereby accommodate or minimize interaction with N137.
On the other hand, selection of the appropriate germline Ab
might be aided by removal of the N137 glycan.
Our efforts to unravel the molecular details that drove the
affinity maturation of the PGT121 lineage yielded an Env trimer
structure at 3.0 A˚ resolution. Previous BG505 SOSIP.664 trimer
crystals (Julien et al., 2013a; Pancera et al., 2014) have suffered
from severe anisotropy, which limits the resolution in some direc-
tions and hence the overall resolution and experimental
completeness of the data. If we compare the ‘‘effective resolu-
tion’’ (Reseff) (Weiss, 2001; Weiss and Hilgenfeld, 1997), where
the high resolution limit is adjusted for data incompleteness
(i.e., resolution 3 completeness 1/3), we see a substantial
improvement, with Reseff = 3.0 A˚ (this work), 4.9 A˚ (PDB:
4NCO) (Julien et al., 2013a), and 3.8 A˚ (PDB: 4TVP) (Pancera
et al., 2014).
The quality of this crystal structure therefore not only improved
the overall accuracy of the three-dimensional model of the Env
trimer, but also added more structural information for regions
not resolved in previous crystal and cryo-EM structures (Julien
et al., 2013a; Lyumkis et al., 2013; Pancera et al., 2014). Although
the structure of the post-fusion conformation of gp41 has long
been known, this is not so for the pre-fusion state, which has
proven to be difficult to determine by X-ray crystallography. An
almost complete trace of gp41 was reported (Pancera et al.,
2014). However, the connecting loop between helices a6
(FPPR) and HR1 (a7) was not resolved. We can now observe
electron density for this region, and the resulting extensive
modeling suggests that we might have captured a structure
that alternates between a helix and an extended structure. Our
structure also explained why the Ile559Pro (‘‘IP’’ in SOSIP) muta-
tion in this region destabilizes the post-fusion form and stabilizes
the pre-fusion form of the Env trimer. The mutation is probably at1060 Immunity 43, 1053–1063, December 15, 2015 ª2015 Elsevier Inthe end of helix 6 and, therefore, prevents formation of a longer
helix as in the fusogenic form, where the fusion peptide becomes
accessible for insertion into the host cell membrane. Thus, this
new structural information can be used for vaccine design by
guiding further structure-based Env trimer variants.
EXPERIMENTAL PROCEDURES
Expression and Purification of Proteins
All Fabs were produced by transient transfection of FreeStyle 293F cells
(Invitrogen) and purified by affinity chromatography followed by cation
exchange chromatography and size exclusion chromatography (SEC) on a
Superdex 200 16/60 column. BG505 SOSIP.664 wild-type and mutant trimers
(SOSIP-137A and SOSIP-N332A) cloned in a phMCV3 vector were expressed
in FreeStyle 293F or 293S cells and purified using a 2G12-coupled affinity
matrix followed by SEC, with exception for the BG505 SOSIP.664 N332A
mutant for which a GN lectin affinity column was used in the initial stage.
The structure-based SOSIP.664 L555K, L556K, and L555C-Q49C mutants
were purified using a PGT145-coupled affinity matrix and then by SEC.
Antibody and Envelope Substitutions
Substitutions in the Env glycoprotein constructs were introduced by Quik-
Change site-directed mutagenesis (Stratagene). Substitutions were verified
by DNA sequencing (Retrogen).
SDS-PAGE and Blue Native-Page
BG505 SOSIP.664 and mutant trimers were analyzed with SDS-PAGE and
BN-PAGE and bands were revealed after staining with Coomassie blue.
Each sample was pre-mixed with loading buffer and shortly after loaded
onto a 4%–12% Bis-Tris NuPAGE gel (Invitrogen). Each run was for 1.5 hr at
200V.
Formation of Protein Complexes and Partial Deglycosylation
Many combinations of ligand-SOSIP.664 trimer complexes, with and without
deglycosylation, were subjected to crystal trials. Generally, trimers and ligands
were mixed in a 1:3.2 molar ratio before SEC purification of the complex. To
decrease heterogeneity on SOSIP.664 trimer:ligand complexes, deglycosyla-
tion was carried out on SOSIP.664 produced in 293S cells with Endoglycosi-
dase H (New England Biolabs) in 200 mM NaCl, 50 mM sodium citrate
(pH 5.5) for 35 min at 37C. Thus, the glycans protected by an interaction
with a Fab are preserved intact, but those accessible to EndoH are trimmed
to the core GlcNAc moiety.
Crystallization and Data Collection
Each Fab was concentrated to 15 mg/ml before being screened against 960
crystallization conditions at both 4C and 20C. High-quality crystals for
9H+3L Fab were obtained from 5% (w/v) PEG 1000, 28% (v/v) PEG 600,
10% (v/v) glycerol, and 0.1 M MES (pH 6.0). For 32H+109L, Fab crystals
appeared in 40% (v/v) PEG 600, 0.1 M NaCl, and 0.1 M Na citrate (pH 5.5).
Crystals were harvested and cryoprotected by brief immersion in well solution
augmented with 30% glycerol, followed by immediate flash cooling in liquid ni-
trogen. Data were collected at Advanced Light Source (ALS) and Advanced
Photon Source (APS). The best 9H+3L crystal diffracted to 2.1 A˚ resolution
and the diffraction data were processed with HKL-2000 (Otwinowski and Mi-
nor, 1997) to an overall Rsym of 0.06% and completeness of 98.4% (Table
S1) in space group P21 with unit cell parameters a = 70.9 A˚, b = 108.7 A˚, c =
72.7 A˚. Data were collected from a 32H+109L crystal to 2.4 A˚ and processed
with HKL-2000 (Otwinowski and Minor, 1997) to an overall Rsym of 0.13% and
completeness of 94.2% (Table S1) in space group P212121 with unit cell pa-
rameters a = 40.7 A˚, b = 338.1 A˚, c = 62.1 A˚.
To determine the molecular footprint and angle of approach of the inferred
3H precursor to the Env trimer, we screened a wide range of crystallization
conditions with many combinations of Fab precursors with the BG505
SOSIP.664 constructs (SOSIP.664 wild-type and SOSIP.664-N137A mutant).
In addition, we used other crystallization additives, such as Fab 35O22, to
facilitate crystal packing (Pancera et al., 2014). The most successful combina-
tion was the 3H+109L Fab with the BG505 SOSIP.664-N137A and the 35O22c.
Fab. Purified ternary complex samples were concentrated to 12 mg/ml and
screened against 480 crystallization conditions at both 4C and 20C. Suitable
crystals were grown in 0.2 M CaCl2, 28% (v/v) PEG 400, and 0.1 M HEPES
(pH 7.5). The complex crystals were cryoprotected by brief immersion in well
solution containing 20% glycerol, followed by immediate flash cooling in liquid
nitrogen. Data were collected at APS beamline 23IDB. Although the best crys-
tal has a few strong reflections visible at 2.7 A˚ resolution, the final dataset was
processed with HKL-2000 (Otwinowski and Minor, 1997) to 3.0 A˚ with an over-
all Rsym of 0.11% and 100% completeness in space group P63 with unit cell
parameters a = b = 128.0 A˚, c = 316.1 A˚ (Table S1).
Structure Determination and Refinement
The unliganded 9H+3L and 32H+109L structures were solved by molecular
replacement (MR) using Phaser with the PGT124 Fab structure (PDB: 4R26),
from which the CDR loops had been deleted, as the initial model. For the
ternary complex, multiple components were used for phasing by MR: one
protomer of 35O22:BG505 SOSIP.664 (PDB: 4TVP) and the high-resolution
unliganded PGT124 Fab. Model building was carried out with Coot (Emsley
and Cowtan, 2004) and refinement was carried out with phenix.refine using
reference model restraints calculated from the structure of Fab 35O22 (PDB:
4TOY) (Adams et al., 2010), respectively.
Final Rcryst and Rfree values for 9H+3L and 32H+109L Fabs structure are
20.0% and 24.4% and 22.4% and 27.3%, respectively. For the complex struc-
ture, the corresponding values are 22.7% and 25.9% (Table S1). For the Fabs,
residues were numbered according to Kabat (Martin, 1996), and gp120
numbered according to the HXBc2 system (Ratner et al., 1987).
Isothermal Titration Calorimetry
ITC experiments were performed with a MicroCal Auto-iTC200 instrument
(GE). All proteins were extensively dialyzed against a buffer containing
20 mM Tris and 150 mM NaCl (pH 7.4) before conducting the titrations.
Subsequently, protein concentrations were adjusted and confirmed by using
calculated extinction coefficients and absorbance at 280 nm. Ligands repre-
senting precursor and mature Abs of the PGT121 family were present in the
syringe at concentrations ranging between 60 and 125 mM. The BG505
SOSIP.664 wild-type and mutants were in the cell at concentrations ranging
between 3.0 and 5.0 mM. Two-protein binding experiments were performed
with the following parameters: cell at 25C, 16 injections of 2.5 ml each, injec-
tion interval of 180 s, injection duration of 5 s, and reference power of 5 mcals.
To calculate the dissociation constants (Kd), the molar reaction enthalpy (DH),
and the stoichiometry of binding (N), Origin 7.0 software was used to fit and
integrate the titration peaks via a single-site binding model.
Electron Microscopy
All complexes were analyzed by negative-stain EM. The 3H+3L Fab complex
was formed with the BG505 SOSIP.664-N137A mutant, whereas 32H+3L Fab
was in complex with the wild-type BG505 SOSIP.664. Both Env proteins were
produced in HEK293S cells. For the 9H+3L complexes, the BG505 SOSIP.664
and BG505 SOSIP.664-N137A trimers were produced in HEK293F cells. A 3 ml
aliquot of 10 mg/ml of the complexwas applied for 15 s onto a glow discharged,
carbon-coated 400 Cu mesh grid and stained with 2% uranyl formate for 20 s.
Grids were imaged using a FEI Tecnai T12 electron microscope operating at
120 kV using 52,0003 magnification and electron dose of 25 e/A˚2, resulting
in a pixel size of 2.05 A˚ at the specimen plane. Images were acquired with a
Tietz 4k 3 4k CCD camera in 5 tilt increments from 0 to 55 at a defocus
of 1,000 nm using LEGINON (Suloway et al., 2005).
Image Processing
Particles were picked automatically by using DoGPicker and put into a particle
stack using the Appion software package (Lander et al., 2009; Voss et al.,
2009). Initial reference-free 2D class averages were calculated using unbinned
particles via the Xmipp Clustering 2D Alignment and sorted into 400 classes
(Sorzano et al., 2010). Particles corresponding to the complexes were selected
into a substack and another round of reference-free alignment was carried out
using Xmipp Clustering 2D alignment and IMAGIC software (van Heel et al.,
1996). To generate an ab initio 3D starting model, a template stack of 120 im-
ages of 2D class averages was used with imposing C3 symmetry. This starting
model was refined against 12,245 raw particles for 30 cycles using EMANImm(Ludtke et al., 1999). The resolution of the final reconstruction for 3H+3L with
BG505 SOSIP.664-N137A was calculated to be 17 A˚, for 9H+3L with BG505
SOSIP.664 was 21 A˚, for 9H+3L with BG505 SOSIP-N137A was 19 A˚, and
for 32H+109L with BG505 SOSIP.664 was 22 A˚ using an FSC cut-off of 0.5
(Figure S2).
Determination of the Approach Angles of the Fabs to gp120 on the
Env Trimer
To measure the differences in angles of approach of different Fabs to the
gp120, we used two complementary methods. First, we superimposed all
the coordinates onto the 4TVP reference structure by their gp120 chains, using
SSM superpose in Coot. Then, to calculate the overall angular difference in
approach, the variable (VL-VH) domains of each Fab were superimposed
with LSQMAN, with the overall angle for that superposition reported. This value
represents the total rotational difference in Fab binding to gp120. The second
measurement again started with all coordinates superimposed by their gp120
chains onto 4TVP.We then calculated an orthogonal set of axes bisecting each
Fab variable domain, with one axis along the pseudo 2-fold axis relating VL and
VH, a second perpendicular axis approximately bisecting the two canonical di-
sulfide bonds in the variable domain, and a third, mutually perpendicular axis.
We next calculated the angle between the pseudo-2-fold axes (these axes
point toward the epicenter of the epitope) and also between the axes bisecting
the canonical disulfides. These two angles define the difference in the overall
angular approach (rotation and tilt) of the Fab to the gp120, and then howmuch
the Fabs rotate to interact with antigen. The sum of these two angles is roughly
equivalent to the total angular difference in binding orientation calculated by
the first method.
Differential Scanning Calorimetry
The thermal stabilities of BG505 SOSIP.664 and mutant trimers were analyzed
on a VP-DSC calorimeter (GE Healthcare).
ACCESSION NUMBERS
Coordinates and structure factors for Fabs 32H+109L and 9H+3L and for the
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tions are deposited in the EMDB under accession codes 6379, 3092, 3093,
and 6380, respectively.
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